SUBSCRIBE
SUBSCRIBE

Apnimed

20 Holyoke Street Cambridge MA 02138 US
Visit website
Email Us
  • Featured Employer
JOBS
IN THE PRESS
Genetown
Apnimed to Participate in the Upcoming Leerink Partners Global Biopharma Conference
March 6, 2024
 · 
3 min read
Genetown
Apnimed to Participate in the Upcoming Evercore ISI 2024 Emerging Biotech Conference
February 22, 2024
 · 
3 min read
Business
Apnimed Announces New Leadership Appointments as the Company Builds Its Commercial and Human Resource Capabilities in Support of AD109, a Potential Nighttime Oral Treatment for Obstructive Sleep Apnea
January 22, 2024
 · 
6 min read
Drug Development
Apnimed Announces First Patient Dosed in SynAIRgy, the Second Phase 3 Clinical Study of AD109, a Potential Nighttime Oral Treatment for Obstructive Sleep Apnea
December 21, 2023
 · 
5 min read
Genetown
Apnimed to Participate in Upcoming November 2023 Investor Conferences
November 6, 2023
 · 
3 min read
Genetown
Apnimed Announces Launch of Joint Venture with Shionogi to Develop Novel Pharmacologic Therapies for Obstructive Sleep Apnea and other Sleep Disorders
October 31, 2023
 · 
5 min read
Genetown
Apnimed to Participate in Upcoming October Investor Conferences
October 11, 2023
 · 
3 min read
Genetown
American Journal of Respiratory and Critical Care Medicine Publishes Full, Positive Results of Apnimed’s MARIPOSA Study on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea
October 10, 2023
 · 
7 min read
Genetown
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
October 2, 2023
 · 
4 min read
Drug Development
Apnimed Announces First Patient Dosed in LunAIRo, the First Phase 3 Clinical Study of AD109, a Potential Nighttime Oral Treatment for Obstructive Sleep Apnea
September 21, 2023
 · 
5 min read
Load More